v3.26.3
Segment and corporate information (Details) - EUR (€)
€ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Dec. 31, 2025
Segment and corporate information          
Revenue from contracts with customers € 4,411,278 € 4,296,863 € 12,874,931 € 12,936,065  
Revenue from insurance contracts 503,784 567,578 1,469,175 1,559,217  
Revenue from lease contracts 21,680 20,409 65,349 62,735  
Revenue 4,936,742 4,884,850 14,409,455 14,558,017  
Costs of revenue (3,661,369) (3,642,632) (10,644,608) (10,917,460)  
Research and development (41,398) (37,748) (119,337) (119,346)  
Operating income (loss) 384,089 476,505 1,136,139 1,233,178  
Interest (81,459) (73,937) (242,994) (229,403)  
Income before income taxes 302,630 402,568 893,145 1,003,775  
Depreciation and amortization (355,801) (358,214) (1,066,861) (1,102,842)  
Impairment loss (77,199) 957 (192,192) (24,013)  
Income (loss) from equity method investees 18,162 46,672 18,228 139,680  
Total assets 31,449,211 30,887,005 31,449,211 30,887,005 € 31,002,333
thereof investment in equity method investees 678,318 751,181 678,318 751,181 € 663,652
Additions of property, plant and equipment, intangible assets and right-of-use assets 363,653 279,452 1,031,717 884,154  
Healthcare services          
Segment and corporate information          
Revenue from contracts with customers 3,312,626 3,219,669 9,709,307 9,721,334  
Revenue 3,312,626 3,219,669 9,709,307 9,721,334  
Healthcare products          
Segment and corporate information          
Revenue from contracts with customers 1,098,652 1,077,194 3,165,624 3,214,731  
Revenue from lease contracts 21,680 20,409 65,349 62,735  
Revenue 1,120,332 1,097,603 3,230,973 3,277,466  
Total Segment          
Segment and corporate information          
Revenue from contracts with customers 4,411,278 4,296,863 12,874,931 12,936,065  
Revenue from insurance contracts 503,784 567,578 1,469,175 1,559,217  
Revenue from lease contracts 21,680 20,409 65,349 62,735  
Revenue 4,936,742 4,884,850 14,409,455 14,558,017  
Total Segment | Healthcare services          
Segment and corporate information          
Revenue from contracts with customers 3,312,626 3,219,669 9,709,307 9,721,334  
Total Segment | Healthcare products          
Segment and corporate information          
Revenue from contracts with customers 1,098,652 1,077,194 3,165,624 3,214,731  
Care Delivery          
Segment and corporate information          
Revenue from contracts with customers 3,356,933 3,273,241 9,869,670 9,863,792  
Revenue 3,356,933 3,273,241 9,869,670 9,863,792  
Care Delivery | Healthcare services          
Segment and corporate information          
Revenue from contracts with customers 3,279,810 3,211,730 9,615,375 9,669,848  
Care Delivery | Healthcare products          
Segment and corporate information          
Revenue from contracts with customers 77,123 61,511 254,295 193,944  
Value-Based Care          
Segment and corporate information          
Revenue from contracts with customers 32,816 7,939 93,932 51,486  
Revenue from insurance contracts 503,784 567,578 1,469,175 1,559,217  
Revenue 536,600 575,517 1,563,107 1,610,703  
Value-Based Care | Healthcare services          
Segment and corporate information          
Revenue from contracts with customers 32,816 7,939 93,932 51,486  
Care Enablement          
Segment and corporate information          
Revenue from contracts with customers 1,021,529 1,015,683 2,911,329 3,020,787  
Revenue from lease contracts 21,680 20,409 65,349 62,735  
Revenue 1,043,209 1,036,092 2,976,678 3,083,522  
Care Enablement | Healthcare products          
Segment and corporate information          
Revenue from contracts with customers 1,021,529 1,015,683 2,911,329 3,020,787  
Care Enablement | Certain pharmaceutical products          
Segment and corporate information          
Revenue from contracts with customers   20,503   59,387  
Operating Segments | Total Segment          
Segment and corporate information          
Revenue 5,479,968 5,337,883 15,948,409 15,915,355  
Costs of revenue (4,159,558) (4,086,886) (12,080,295) (12,254,410)  
Research and development (41,398) (37,954) (119,337) (119,552)  
Operating income (loss) 464,567 484,166 1,362,879 1,328,296  
Depreciation and amortization (352,356) (352,003) (1,054,168) (1,082,875)  
Impairment loss (76,972) 941 (156,635) (24,029)  
Income (loss) from equity method investees 18,162 46,672 18,228 139,680  
Total assets 56,712,904 55,535,068 56,712,904 55,535,068  
thereof investment in equity method investees 678,318 751,181 678,318 751,181  
Additions of property, plant and equipment, intangible assets and right-of-use assets 373,829 275,252 1,058,547 888,758  
Operating Segments | Care Delivery          
Segment and corporate information          
Revenue 3,491,930 3,401,706 10,263,812 10,229,217  
Costs of revenue (2,628,106) (2,564,750) (7,769,544) (7,907,680)  
Operating income (loss) 496,903 419,474 1,203,037 1,085,873  
Depreciation and amortization (234,281) (235,080) (697,412) (739,402)  
Impairment loss (714) (257) (76,114) (17,336)  
Income (loss) from equity method investees 18,162 46,672 18,228 139,680  
Total assets 42,136,948 40,572,794 42,136,948 40,572,794  
thereof investment in equity method investees 678,318 751,181 678,318 751,181  
Additions of property, plant and equipment, intangible assets and right-of-use assets 252,614 143,797 706,814 531,282  
Operating Segments | Value-Based Care          
Segment and corporate information          
Revenue 536,600 575,517 1,563,107 1,610,703  
Costs of revenue (514,316) (579,371) (1,461,024) (1,558,685)  
Operating income (loss) 94 (21,960) 6,386 (27,553)  
Depreciation and amortization (193) (1,354) (1,048) (4,030)  
Impairment loss   21   (2,171)  
Total assets 642,093 584,495 642,093 584,495  
Additions of property, plant and equipment, intangible assets and right-of-use assets 94 117 235 315  
Operating Segments | Care Enablement          
Segment and corporate information          
Revenue 1,451,438 1,360,660 4,121,490 4,075,435  
Costs of revenue (1,017,136) (942,765) (2,849,727) (2,788,045)  
Research and development (41,398) (37,954) (119,337) (119,552)  
Operating income (loss) (32,430) 86,652 153,456 269,976  
Depreciation and amortization (117,882) (115,569) (355,708) (339,443)  
Impairment loss (76,258) 1,177 (80,521) (4,522)  
Total assets 13,933,863 14,377,779 13,933,863 14,377,779  
Additions of property, plant and equipment, intangible assets and right-of-use assets 121,121 131,338 351,498 357,161  
Operating Segments | Care Enablement | Certain pharmaceutical products          
Segment and corporate information          
Costs of revenue   (15,098)   (45,017)  
Operating income (loss)   3,146   7,013  
Operating Segments | Corporate          
Segment and corporate information          
Costs of revenue 1,377 (4,333) 3,767 (2,243)  
Research and development   206   206  
Operating income (loss) (34,065) (4,207) (119,706) (77,965)  
Depreciation and amortization (13,790) (16,569) (42,965) (50,567)  
Impairment loss (227) 16 (35,557) 16  
Total assets 11,268,977 11,344,082 11,268,977 11,344,082  
Additions of property, plant and equipment, intangible assets and right-of-use assets 42,851 14,763 102,216 26,738  
Inter-segment          
Segment and corporate information          
Revenue (543,226) (453,033) (1,538,954) (1,357,338)  
Costs of revenue 496,812 448,587 1,431,920 1,339,193  
Operating income (loss) (46,413) (3,454) (107,034) (17,153)  
Depreciation and amortization 10,345 10,358 30,272 30,600  
Total assets (36,532,670) (35,992,145) (36,532,670) (35,992,145)  
Additions of property, plant and equipment, intangible assets and right-of-use assets (53,027) (10,563) (129,046) (31,342)  
Inter-segment | Total Segment          
Segment and corporate information          
Revenue (543,226) (453,033) (1,538,954) (1,357,338)  
Inter-segment | Care Delivery          
Segment and corporate information          
Revenue (134,997) (128,465) (394,142) (365,425)  
Inter-segment | Care Enablement          
Segment and corporate information          
Revenue € (408,229) (324,568) € (1,144,812) (991,913)  
Inter-segment | Care Enablement | Certain pharmaceutical products          
Segment and corporate information          
Revenue   € (1,586)   € (4,179)